Octreotide Acetate Peptide Tablet Powder CAS 79517-01-4
- Aruj
- 25/11/2024 11:49
Office
-
Company name
Octreotide Acetate Peptide Tablet Powder CAS 79517-01-4
-
Workspace
Healthcare, Pharmacy
-
Schedule
Full time
-
Education
Secondary
-
Experience
Octreotide Acetate (CAS 79517-01-4)
Alternate Names:
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate
Application:
Octreotide Acetate is an octapeptide analog of Somatostatin
CAS Number: 79517-01-4
Molecular Weight: 1079.29
Molecular Formula: C51H70N10O12S2
Somatostatin analogue with antiproliferative effect. It is able to inhibit angiogenesis induced by hepatocellular carcinoma in vivo, and Akt/PKB and telomerase activity of SGC7901 cells. -
Sex
-
Age
-
Description
-
Octreotide Acetate (CAS 79517-01-4)
Alternate Names:
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate
Application:
Octreotide Acetate is an octapeptide analog of Somatostatin
CAS Number: 79517-01-4
Molecular Weight: 1079.29
Molecular Formula: C51H70N10O12S2
Somatostatin analogue with antiproliferative effect. It is able to inhibit angiogenesis induced by hepatocellular carcinoma in vivo, and Akt/PKB and telomerase activity of SGC7901 cells.
